IRIS
PETRIOLI, ROBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.926
EU - Europa 3.932
AS - Asia 2.217
SA - Sud America 334
AF - Africa 118
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 1
Totale 11.537
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.846
RU - Federazione Russa 1.012
GB - Regno Unito 726
SG - Singapore 696
CN - Cina 691
IE - Irlanda 541
IT - Italia 445
VN - Vietnam 312
BR - Brasile 264
SE - Svezia 254
DE - Germania 210
UA - Ucraina 209
FR - Francia 193
HK - Hong Kong 182
FI - Finlandia 107
IN - India 76
KR - Corea 74
ZA - Sudafrica 62
CA - Canada 56
ES - Italia 50
BE - Belgio 40
AR - Argentina 26
PL - Polonia 26
BD - Bangladesh 25
NL - Olanda 23
LU - Lussemburgo 22
IQ - Iraq 20
MX - Messico 19
TR - Turchia 19
JP - Giappone 18
CI - Costa d'Avorio 14
CL - Cile 14
AT - Austria 12
NG - Nigeria 12
PK - Pakistan 12
LT - Lituania 11
IR - Iran 9
VE - Venezuela 9
CZ - Repubblica Ceca 8
ID - Indonesia 8
JO - Giordania 8
MA - Marocco 8
SA - Arabia Saudita 8
AE - Emirati Arabi Uniti 7
RO - Romania 7
AU - Australia 6
CO - Colombia 6
EC - Ecuador 6
KZ - Kazakistan 6
PH - Filippine 6
CH - Svizzera 5
MY - Malesia 5
TH - Thailandia 5
AZ - Azerbaigian 4
BG - Bulgaria 4
TN - Tunisia 4
UZ - Uzbekistan 4
DK - Danimarca 3
ET - Etiopia 3
KE - Kenya 3
LV - Lettonia 3
MM - Myanmar 3
NO - Norvegia 3
NP - Nepal 3
PY - Paraguay 3
TW - Taiwan 3
UY - Uruguay 3
AL - Albania 2
AO - Angola 2
DZ - Algeria 2
EE - Estonia 2
EG - Egitto 2
GR - Grecia 2
HU - Ungheria 2
IL - Israele 2
KG - Kirghizistan 2
LB - Libano 2
MD - Moldavia 2
MW - Malawi 2
NZ - Nuova Zelanda 2
PE - Perù 2
PT - Portogallo 2
SI - Slovenia 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BO - Bolivia 1
BW - Botswana 1
CR - Costa Rica 1
EU - Europa 1
FJ - Figi 1
GE - Georgia 1
GN - Guinea 1
GT - Guatemala 1
HN - Honduras 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
MT - Malta 1
NI - Nicaragua 1
QA - Qatar 1
Totale 11.531
Salva come PNG Salva come JPEG
Città #
Dallas 690
Southend 619
Dublin 536
Fairfield 522
Singapore 413
Ashburn 385
Moscow 309
Woodbridge 242
Chandler 227
Santa Clara 221
Ann Arbor 210
Wilmington 196
Cambridge 183
Seattle 180
Beijing 175
Jacksonville 175
Houston 171
Hong Kong 170
San Jose 166
New York 96
Ho Chi Minh City 94
Los Angeles 93
Siena 91
Princeton 87
Hefei 84
Munich 76
Hanoi 73
Seoul 72
Johannesburg 62
Lauterbourg 56
Nanjing 54
Helsinki 50
Shanghai 46
The Dalles 46
Council Bluffs 42
Milan 40
Brussels 39
San Mateo 38
Málaga 36
Florence 32
Boardman 30
Dong Ket 29
São Paulo 27
San Diego 26
Columbus 25
Buffalo 24
London 23
Orem 23
Shenyang 22
Montreal 20
Turku 20
San Francisco 19
Warsaw 19
Chennai 18
Rome 18
Da Nang 16
Frankfurt am Main 16
Nanchang 16
Tokyo 16
Denver 15
Jiaxing 15
Abidjan 14
Nuremberg 14
Roodt-sur-Syre 14
Atlanta 13
Brooklyn 12
Haiphong 12
Kunming 12
Manchester 12
Redondo Beach 12
Toronto 12
Abuja 11
Baghdad 11
Guangzhou 11
Chicago 10
Hebei 10
Phoenix 10
Tianjin 10
Venezia 10
Zhengzhou 10
Düsseldorf 9
Pisa 9
Poplar 9
Santiago 9
Arezzo 8
Boston 8
Changsha 8
Portsmouth 8
Washington 8
Bengaluru 7
Dhaka 7
Mexico City 7
Mumbai 7
North Bergen 7
Stockholm 7
Amman 6
Amsterdam 6
Aosta 6
Belo Horizonte 6
Dearborn 6
Totale 7.902
Salva come PNG Salva come JPEG
Nome #
C-Met targeting in advanced gastric cancer: An open challenge 327
Efficacy and Safety of Regorafenib With 2/1 Schedule for Patients ≥ 75 Years With Metastatic Colorectal Cancer (mCRC) After Failure of 2 Lines of Chemotherapy 314
Pathological response and outcome after neoadjuvant chemotherapy with DOC (docetaxel, oxaliplatin, capecitabine) or EOF (epirubicin, oxaliplatin, 5-fluorouracil) for clinical T3-T4 non-metastatic gastric cancer 308
28. Role of neoadjuvant chemotherapy with cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy for treatment of primary ovarian cancer with peritoneal carcinomatosis 305
Angiogenesis inhibitors in gastric and gastroesophageal junction cancer 297
Feasibility of modified docetaxel, oxaliplatin, capecitabine followed by capecitabine as maintenance chemotherapy as first-line therapy for patients with metastatic gastric or gastroesophageal cancer 281
A novel treatment protocol with 6 cycles of neoadjuvant chemotherapy followed by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) in stage III primary ovarian cancer 276
Monoclonal antibodies-based treatment in gastric cancer: current status and future perspectives 269
Apatinib: A novel receptor tyrosine kinase inhibitor for the treatment of gastric cancer 256
Efficacy of Adjuvant Fluorouracil and Folinic Acid in B2 Colon Cancer 256
Maintenance treatment with oral cyclophosphamide and bevacizumab in patients with recurrent epithelial ovarian cancer 255
Strong Prognostic Value of Microsatellite Instability in Intestinal Type Non-cardia Gastric Cancer 255
Signet ring cell percentage in poorly cohesive gastric cancer patients: a potential novel predictor of survival 255
Analysis of biochemical bone markers as prognostic factors for survival in patients with hormone-resistant prostate cancer and bone metastases 254
Two-point-NGS analysis of cancer genes in cell-free DNA of metastatic cancer patients 251
CEA and CA19.9 as early predictors of progression in advanced/metastatic colorectal cancer patients receiving oxaliplatin-based chemotherapy and bevacizumab 242
Gemcitabine, oxaliplatin, and capecitabine (GEMOXEL) compared with gemcitabine alone in metastatic pancreatic cancer: a randomized phase II study 241
Hyperthermic intraperitoneal chemotherapy for the treatment of ovarian cancer: A brief overview of recent results 239
The percentage of signet ring cells is inversely related to aggressive behavior and poor prognosis in mixed-type gastric cancer 237
A husband and a wife with simultaneous presentation of glioblastoma multiforme: a case report 213
Sequential treatment with epirubicin, oxaliplatin and 5FU (EOF) followed by docetaxel, oxaliplatin and 5FU (DOF) in patients with advanced gastric or gastroesophageal cancer: a single-institution experience 212
A case of eribulin-induced regression of liposarcoma of the left funiculus in a heavily pretreated patient 208
GEMCITABINE (dFdC), 5-FLUROURACIL (5FU), AND FOLINIC ACID (FA) IN THE TREATMENT OF PATIENTS WITH GASTRO-ENTERIC CARCINOMAS: A CLINICAL AND PHARMACOLOGICAL STUDY. 202
Treatment of advanced oesophagogastric cancer with FOLFOX-4 regimen followed by leucovorin/bolus and continuous infusion 5-FU as maintenance chemotherapy in patients aged ≥ 75 years with impaired performance status 201
Gastric cancer: Current status of lymph node dissection 191
The prognostic value of CD3+ tumor-infiltrating lymphocytes for stage II colon cancer according to use of adjuvant chemotherapy: A large single-institution cohort study: TILs for ADJ-untreated stage II colon cancer 191
Combined tamoxifen and luteinizing hormone-releasing hormone (LHRH) agonist versus LHRH agonist alone in premenopausal advanced breast cancer: A meta-analysis of four randomized trials 190
Short-term and long-term risk factors in gastric cancer 189
Capecitabine Plus Oxaliplatin and Bevacizumab, Followed by Maintenance Treatment With Capecitabine and Bevacizumab for Patients Aged > 75 Years With Metastatic Colorectal Cancer 189
Maximum androgen blockade in advanced prostate cancer: an overview of the randomised trials 183
Epirubicin-based compared with docetaxel-based chemotherapy for advanced gastric carcinoma: A systematic review and meta-analysis 171
Hyperprogressive disease in advanced cancer patients treated with nivolumab: a case series study 164
An exceptional overall survival using bevacizumab beyond progression in a patient with Non-small cell lung cancer 163
Clinical value and impact on prognosis of peri-operative CA 19-9 serum levels in stage I and II adenocarcinoma of the pancreas 162
Gemcitabine plus nab-paclitaxel followed by maintenance treatment with gemcitabine alone as first-line treatment for older adults with locally advanced or metastatic pancreatic cancer 159
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for treatment of ovarian cancer 158
Posterior and Para-Aortic (D2plus) Lymphadenectomy after Neoadjuvant/Conversion Therapy for Locally Advanced/Oligometastatic Gastric Cancer 156
Cytoreduction surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) as treatment choice of metastatic Urachal carcinoma 148
Association of Concomitant Bone Resorption Inhibitors with Overall Survival among Patients with Metastatic Castration-Resistant Prostate Cancer and Bone Metastases Receiving Abiraterone Acetate with Prednisone as First-Line Therapy 146
Preoperative or perioperative docetaxel, oxaliplatin, and capecitabine (GASTRODOC regimen) in patients with locally-advanced resectable gastric cancer: a randomized phase-II trial 145
Evolution and emerging future of cytoreducxtive surgery and hyperthermic intraperitoneal chemoperfusion in gastric cancer: From treating the incurable to preventing recurrence 144
Structured and shared CT radiological report of gastric cancer: a consensus proposal by the Italian Research Group for Gastric Cancer (GIRCG) and the Italian Society of Medical and Interventional Radiology (SIRM) 139
Five years of stable disease with maintenance therapy using bevacizumab and tamoxifen in a patient with metastatic breast cancer 134
Neuroendocrine tumors' patients treated with somatostatin analogue could complicate with emergency cholecystectomy 133
Impact of HER2 and microsatellite instability status on response to neoadjuvant/conversion therapy and survival in patients with gastric cancer 129
Thymostimulin in Association with Chemotherapy in Breast Cancer Patients with Bone Metastases 121
Specific clonal expansion at disease progression (PD) in solid cancers pinpointed by cell free DNA analysis 119
Squamous cell carcinoma of the maxillary sinus: A retrospective analysis of 36 cases 118
Low-Dose Estramustine Phosphate and Concomitant Low-Dose Acetylsalicylic Acid in Heavily Pretreated Patients With Advanced Castration-Resistant Prostate Cancer. 117
Role of chemotherapy in the treatment of metastatic castration-resistant prostate cancer patients who have progressed after abiraterone acetate 114
null 112
null 112
null 110
null 109
Tolerability of cabazitaxel in patients with metastatic castration-resistant prostate cancer progressing after docetaxel and abiraterone acetate: a single-institution experience. 105
null 103
Surgical management of advanced gastric cancer: An evolving issue 99
null 98
null 98
null 96
null 96
null 89
null 88
null 87
Pressurized Intra-Peritoneal Aerosol Chemotherapy (PIPAC) for Peritoneal Malignancies with Palliative and Bidirectional Intent 81
Rare variants modulating phenotype in NF1 carriers 63
null 39
Totale 11.712
Salva come PNG Salva come JPEG
Categoria #
all - tutte 35.175
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.175
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021299 0 0 0 0 0 0 0 0 0 133 84 82
2021/2022707 57 63 49 45 30 37 30 32 32 71 97 164
2022/2023953 55 69 137 106 85 201 31 78 96 46 26 23
2023/2024898 33 16 87 45 27 231 300 9 0 45 48 57
2024/20251.629 63 94 160 115 221 108 32 92 161 54 205 324
2025/20264.202 336 551 576 567 955 192 539 121 160 205 0 0
Totale 11.712